Fingerprint
Dive into the research topics of 'In Vivo Veritas - 18F-radiolabeled glycomimetics allow insights into the pharmacological fate of galectin-3 inhibitors'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
In Vivo Veritas - 18F-radiolabeled glycomimetics allow insights into the pharmacological fate of galectin-3 inhibitors
Klas Bratteby, Edvard Torkelsson, Elina Tampio L'Estrade, Kristoffer Peterson, Vladimir Shalgunov, Mengfei Xiong, Hakon Leffler, Fredrik Zetterberg, Tomas G Olsson, Nic Gillings, Ulf J Nilsson, Matthias M Herth, Maria Erlandsson